First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial
Top Cited Papers
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9336) , 817-824
- https://doi.org/10.1016/s0140-6736(02)09962-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of GuernseyBritish Journal of Cancer, 1997
- Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programmeEuropean Journal of Cancer and Clinical Oncology, 1990
- THE PREVENTION OF BREAST CANCERThe Lancet, 1986
- TAMOXIFEN AND CONTRALATERAL BREAST CANCERThe Lancet, 1985
- ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancerNature, 1983
- Hormonal Pathogenesis of Adenocarcinoma of the BreastThe American Journal of Cancer, 1936
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896